{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:23:13Z","timestamp":1794939793821,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recurrent bacterial infections of the respiratory tract are one of the major clinical features of the primary ciliary dyskinesia (PCD), a rare genetic disease due to malfunctioning of motile cilia. Chronic infections and persistent inflammation of the respiratory system result in progressive lung disease.<\/jats:p>\n                <jats:p>Aim of the study was to highlight the main factors associated with clinical, functional and anatomical deterioration in PCD patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed data from 58 patients with PCD, 37 adults and 21 children. The demographic and clinical data, forced expiratory volume at 1\u2009s (FEV<jats:sub>1<\/jats:sub>) and forced vital capacity (FVC), sputum microbiology and imaging results (chest CT scores-modified Bhalla) were recorded. Patients were stratified according to the number of exacerbations (&lt;\u20092\/year vs\u2009\u2265\u20092\/year) and chronic <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (PA) colonization. The possible correlations between lung function and chest CT scores were assessed; we also evaluated the correlation between these parameters and the severity scores for bronchiectasis (BSI, FACED and e-FACED).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Chest CT scores showed a significant correlation with FEV<jats:sub>1<\/jats:sub> (<jats:italic>p<\/jats:italic>\u2009=\u20090.0002), age (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.0001), BMI (p\u2009=\u20090.0002) and number of lung lobes involved (p\u2009&lt;\u2009\u00a00.0001). PA colonization had an overall prevalence of 32.6%: no significant difference in FEV<jats:sub>1<\/jats:sub> between PA colonized and non-colonized patients was found (<jats:italic>p<\/jats:italic>\u2009=\u20090.70), while chest CT score was significantly worse in chronic PA colonized patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.009). Patients with a high number of exacerbation (\u2265 2\/year) were older (<jats:italic>p<\/jats:italic>\u2009=\u20090.01), had lower FEV<jats:sub>1<\/jats:sub> (<jats:italic>p<\/jats:italic>\u2009=\u20090.03), greater number of lobes involved (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and worse CT score than patients with low number of exacerbations (<jats:italic>p<\/jats:italic>\u2009=\u20090.001); they also had higher prevalence of PA chronic bronchial infection (33.3% versus 13.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.10). Multivariable linear regression analyses adjusted for gender, age and BMI showed positive associations between PA colonization and number of exacerbations with severity of disease (number of lobes involved, CT score, BSI, FACED, and e-FACED).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In our PCD population the number of exacerbations (\u2265 2\/year) and PA colonization were the two most relevant factors associated with severity of disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-020-02062-4","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T08:02:26Z","timestamp":1586764946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Exacerbations and Pseudomonas aeruginosa colonization are associated with altered lung structure and function in primary ciliary dyskinesia"],"prefix":"10.1186","volume":"20","author":[{"given":"G.","family":"Piatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"De Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Farolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V.","family":"Zuccotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"D\u2019Auria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Patria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Torretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Consonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Ambrosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"2062_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/BF02141468","volume":"82","author":"M Kartagener","year":"1933","unstructured":"Kartagener M. Zur pathogenese der bronkiectasien. Bronkiectasien bei situs viscerum inversus. Beitr Klin Tuberk. 1933;82:489\u2013501.","journal-title":"Beitr Klin Tuberk"},{"key":"2062_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1126\/science.1084576","volume":"193","author":"BA Afzelius","year":"1976","unstructured":"Afzelius BA. A human syndrome caused by immotile cilia. Science. 1976;193:317\u20139.","journal-title":"Science"},{"key":"2062_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/thx.53.10.894","volume":"53","author":"BA Afzelius","year":"1988","unstructured":"Afzelius BA. Immotile cilia syndrome: past, present and prospects for the future. Thorax. 1988;53:894\u20137.","journal-title":"Thorax"},{"key":"2062_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1164\/rccm.200303-365OC","volume":"169","author":"PG Noone","year":"2004","unstructured":"Noone PG, Leigh MW, Sannuti A, Minnix SL, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Resp Crit Care Med. 2004;169:459\u201367.","journal-title":"Am J Resp Crit Care Med"},{"issue":"8","key":"2062_CR5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1164\/rccm.201301-0059CI","volume":"188","author":"MR Knowles","year":"2013","unstructured":"Knowles MR, Daniels LA, Davis SD, Zariwala MA, et al. Primary ciliary dyskinesia: recent advances in diagnostics, genetics and characterization of clinical disease. Am J Resp Crit Care Med. 2013;188(8):913\u201322.","journal-title":"Am J Resp Crit Care Med"},{"key":"2062_CR6","doi-asserted-by":"crossref","unstructured":"Chapelin C, Coste A, Reinert P, Boucherat M, Millepied MC et a. Incidence of PCD in children with recurrent respiratory diseases. Ann Otol Rhinol Laryngol 1997;106:854\u2013858.","DOI":"10.1177\/000348949710601008"},{"key":"2062_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13630-014-0011-8","volume":"4","author":"C Werner","year":"2015","unstructured":"Werner C, Onnebrink JG, Omran H. Diagnosis and management of primary ciliary dyskinesia. Cilia. 2015;4:2\u20139.","journal-title":"Cilia"},{"key":"2062_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ppul.23304","volume":"51","author":"AJ Shapiro","year":"2016","unstructured":"Shapiro AJ, Zariwala MA, Ferkol T, et al. Diagnosis, monitoring and treatment of primary ciliary dyskinesia: PCD Foundation consensus recommendations based on state of art review. Pediatr Pulmonol. 2016;51:115\u201332.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"2062_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01090-2016","volume":"49","author":"JS Lucas","year":"2017","unstructured":"Lucas JS, Barbato A, Collins SA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. ERJ. 2017;49(1):1\u201325.","journal-title":"ERJ"},{"key":"2062_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2017.00084","volume":"5","author":"AM Nathan","year":"2017","unstructured":"Nathan AM, De Bruyne JA, Peng Eg K, Thavagnanam S. Review: quality of life in children with non-cystic fibrosis bronchiectasis. Front Pediatr. 2017;5:1\u20138.","journal-title":"Front Pediatr"},{"key":"2062_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1378\/chest.07-2812","volume":"134","author":"F Santamaria","year":"2008","unstructured":"Santamaria F, Montella S, Tiddens AWM, Guidi G, et al. Structural and functional lung disease in primary Ciliary dyskinesia. Chest. 2008;134:351\u20137.","journal-title":"Chest"},{"key":"2062_CR12","doi-asserted-by":"publisher","first-page":"1093e1","DOI":"10.1016\/j.cmi.2015.08.020","volume":"21","author":"MC Alanin","year":"2015","unstructured":"Alanin MC, Wijers CDM, Nielsen KG, von Buchwald C, Skov M, et al. A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia. Clin Microbiol Infect. 2015;21:1093e1\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"2062_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/1479972317694621","volume":"14","author":"CDM Wijers","year":"2017","unstructured":"Wijers CDM, Chmiel JF, Gaston BM. Bacterial infections in patients with primary ciliary dyskinesia: comparison with cystic fibrosis. Chronic Resp Dis. 2017;14(4):392\u2013406.","journal-title":"Chronic Resp Dis"},{"key":"2062_CR14","doi-asserted-by":"publisher","first-page":"00147","DOI":"10.1183\/23120541.00147-2018","volume":"5","author":"JS Lucas","year":"2019","unstructured":"Lucas JS, Gahleitner F, Amorim A, Boon M, et al. Pulmonary exacerbations in patients with primary ciliary dyskinesia: an expert consensus definition for use in clinical trials. ERJ Open Res. 2019;5:00147\u20132018.","journal-title":"ERJ Open Res"},{"key":"2062_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/ppul.23479","volume":"51","author":"M Sunter","year":"2016","unstructured":"Sunter M, Bush A, Hogg C, McCann L, Carr SB. Recovery of baseline lung function after pulmonary exacerbation in children with PCD. Pediatr Pulmonol. 2016;51:1362\u20136.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"2062_CR16","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1378\/chest.07-0490","volume":"132","author":"MA Martinez-Garcia","year":"2007","unstructured":"Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J. Factors associated with lung function decline in adults patients with stable non-cystic bronchiectasis. Chest. 2007;132(5):1565\u201372.","journal-title":"Chest"},{"key":"2062_CR17","first-page":"A1798","volume":"191","author":"H Chang","year":"2015","unstructured":"Chang H, Adjemian J, Dell SDM, et al. Prevalence of airway microbial flora in primary ciliary dyskinesia. Am J Respir Crit Care Med. 2015;191:A1798.","journal-title":"Am J Respir Crit Care Med"},{"key":"2062_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.rmed.2017.08.028","volume":"131","author":"M Cohen Cymberknoh","year":"2017","unstructured":"Cohen Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, et al. Clinical impact of Pseudomonas aeruginosa colonization in patients with primary Ciliary dyskinesia. Resp Med. 2017;131:241\u20136.","journal-title":"Resp Med"},{"key":"2062_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1128\/CMR.00068-09","volume":"23","author":"JJ LiPuma","year":"2010","unstructured":"LiPuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23:299\u2013323.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2062_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ppul.10127","volume":"34","author":"J Emerson","year":"2002","unstructured":"Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91\u2013100.","journal-title":"Pediatr Pulmonol"},{"key":"2062_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1183\/09031936.00046209","volume":"35","author":"JF Papon","year":"2010","unstructured":"Papon JF, Coste A, Roudot-Thoraval FR, et al. A 20-year experience of electron microscopy in the diagnosis of primary ciliary dyskinesia. Eur Resp J. 2010;35:1057\u201363.","journal-title":"Eur Resp J"},{"issue":"3","key":"2062_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1183\/09031936.00108410","volume":"38","author":"C O\u2019Callaghan","year":"2011","unstructured":"O\u2019Callaghan C, Rutman A, Williams GM, Hirst RA. Inner dynein arm defects causing primary ciliary dyskinesia: repeat testing required. Eur Resp J. 2011;38(3):603\u20137.","journal-title":"Eur Resp J"},{"issue":"3","key":"2062_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1183\/20734735.008517","volume":"13","author":"CE Kuehni","year":"2017","unstructured":"Kuehni CE, Lucas JS. Diagnosis of primary ciliary dyskinesia: summary of ERS task force report. Breathe. 2017;13(3):167\u201378.","journal-title":"Breathe"},{"key":"2062_CR24","doi-asserted-by":"crossref","unstructured":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Resp Crit Care Med. 2005;171(8):912\u2013930.","DOI":"10.1164\/rccm.200406-710ST"},{"key":"2062_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1513\/AnnalsATS.201305-110OC","volume":"10","author":"MW Leigh","year":"2013","unstructured":"Leigh MW, Hazucha MJ, Chawla KK. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc. 2013;10:574\u201381.","journal-title":"Ann Am Thorac Soc"},{"key":"2062_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1183\/13993003.00749-2015","volume":"47","author":"CL Jackson","year":"2016","unstructured":"Jackson CL, Behan L, Collins SA, et al. Accuracy of diagnostic testing in primary ciliary dyskinesia. Eur Resp J. 2016;47:837\u201348.","journal-title":"Eur Resp J"},{"issue":"2","key":"2062_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.phrs.2004.07.006","volume":"51","author":"G Piatti","year":"2005","unstructured":"Piatti G, Ambrosetti U, Santus P, Allegra L. Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacol Res. 2005;51(2):165\u20138.","journal-title":"Pharmacol Res"},{"key":"2062_CR28","doi-asserted-by":"crossref","unstructured":"Shoemark A, Boon M, Brocchhausen C, Bukowy-Bieryllo Z et al. International consensus guideline for reporting transmission electron microscopy results in the diagnosis of primary Ciliary dyskinesia (BEAT PCD TEM criteria). ERJ 2020. 14 (in press).","DOI":"10.1183\/13993003.00725-2019"},{"issue":"8","key":"2062_CR29","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/humrep\/den193","volume":"23","author":"D Zuccarello","year":"2008","unstructured":"Zuccarello D, Ferlin A, Cassadore C, Pepe A, Garolla A, Moretti A, Cordeschi G, et al. Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. Hum Reprod. 2008;23(8):1957\u201362.","journal-title":"Hum Reprod"},{"key":"2062_CR30","doi-asserted-by":"crossref","unstructured":"ATS\/ERS Task force: standardization of lung function testing. Interpretative strategies for lung function test. ERJ. 2005;26:948\u2013968.","DOI":"10.1183\/09031936.05.00035205"},{"issue":"3","key":"2062_CR31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00004728-198206000-00001","volume":"6","author":"DP Naidich","year":"1982","unstructured":"Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comput Assit Tomogr. 1982;6(3):437\u201344.","journal-title":"J Comput Assit Tomogr"},{"key":"2062_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","volume":"179","author":"M Bhalla","year":"1991","unstructured":"Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin sections CT. Radiology. 1991;179:783\u20138.","journal-title":"Radiology"},{"issue":"5","key":"2062_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2062_CR34","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","volume":"43","author":"MA Martinez-Garcia","year":"2014","unstructured":"Martinez-Garcia MA, DE Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Resp J. 2014;43(5):1357\u201367.","journal-title":"Eur Resp J"},{"key":"2062_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","volume":"12","author":"MA Martinez-Garcia","year":"2017","unstructured":"Martinez-Garcia MA, Athanazio RA, Giron R, Maiz-Carro L, et al. Predicting high risk of exacerbations in bronchiectasis: the e-FACED score. Internat J COPD. 2017;12:275\u201384.","journal-title":"Internat J COPD"},{"issue":"4 Pt 1","key":"2062_CR36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","volume":"162","author":"MCMC Pasteur","year":"2000","unstructured":"Pasteur MCMC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Resp Crit Care Med. 2000;162(4 Pt 1):1277\u201384.","journal-title":"Am J Resp Crit Care Med"},{"issue":"2","key":"2062_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1183\/13993003.00209-2016","volume":"48","author":"A Shah","year":"2016","unstructured":"Shah A, Shoemark A, MacNeill SJ, Bhaludin B, et al. A longitudinal study characterising a large adult primary ciliary dyskinesia population. ERJ. 2016;48(2):441\u201350.","journal-title":"ERJ"},{"key":"2062_CR38","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/ppul.22577","volume":"47","author":"M L\u00e9mery-Magnin","year":"2012","unstructured":"L\u00e9mery-Magnin M, Cros P, Beydon N, et al. Longitudinal lung function and structural changes in children with primary Ciliary dyskinesia. Pediatr Pulmonol. 2012;47:816\u201325.","journal-title":"Pediatr Pulmonol"},{"key":"2062_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/thoraxjnl-2015-207891","volume":"72","author":"J Frija-Masson","year":"2017","unstructured":"Frija-Masson J, Bassinet L, Honor\u00e9 I, et al. Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia. Thorax. 2017;72:154\u201360.","journal-title":"Thorax"},{"key":"2062_CR40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1183\/13993003.01390-2015","volume":"47","author":"F Ratjen","year":"2016","unstructured":"Ratjen F, Waters V, Klingel M, McDonald N, et al. Changes in airway inflammation during pulmonary exacerbations in patients with CF and PCD. ERJ. 2016;47:829\u201336.","journal-title":"ERJ"},{"issue":"S1","key":"2062_CR41","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1080\/15412555.2017.1286171","volume":"14","author":"JD Chalmers","year":"2017","unstructured":"Chalmers JD. Bronchiectasis: phenotyping a complex disease. COPD: J Chron Obstruct Pulmon Dis. 2017;14(S1):S12\u20138.","journal-title":"COPD: J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"2062_CR42","first-page":"190","volume":"199","author":"SD Davis","year":"2019","unstructured":"Davis SD, Rosenfeld M, Lee HS, Ferkol TV, et al. Primary ciliary dyskinesia: longitudinal study of lung disease by ultrastructure defect and genotype. AJRCCM. 2019;199(2):190\u20138.","journal-title":"AJRCCM"},{"issue":"11","key":"2062_CR43","first-page":"1602","volume":"12","author":"S Finch","year":"2015","unstructured":"Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, et al. A comprehensive analysis of the impact of PA colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12(11):1602\u201311.","journal-title":"Ann Am Thorac Soc"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02062-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-020-02062-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02062-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T23:12:27Z","timestamp":1618269147000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-02062-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2062"],"URL":"https:\/\/doi.org\/10.1186\/s12887-020-02062-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,13]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethical Committee of the Fondazione IRCCS Ca\u2032 Granda Ospedale Maggiore Policlinico approved protocol. All patients or parents of children signed an informed consent to the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}